Physician profile
Asha Murthy
NPI 1578524476
$3,433.05
in general payments reported to CMS, 2019-2025
45 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $277 · 2021: $315 · 2022: $826 · 2023: $1,109 · 2024: $152 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405 · Education: $86.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.27 |
| Education | $86.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $370.19 | 2019-2025 | Imdelltra (Amg757), Xgeva, Vectibix |
| Novartis Pharmaceuticals Corporation | $260.49 | 2019-2025 | |
| Celgene Corporation | $220.30 | 2021-2023 | Pomalyst, Reblozyl |
| Pfizer INC. | $180.38 | 2022-2024 | |
| Janssen Biotech, INC. | $159.42 | 2021-2023 | Erleada, Akeega |
| Lilly USA, LLC | $157.28 | 2019-2021 | |
| Tempus Ai, INC | $129.96 | 2024-2025 | Xt Cdx |
| E.R. Squibb & Sons, L.L.C. | $119.19 | 2019-2023 | |
| Gilead Sciences, INC. | $111.46 | 2022-2023 | Trodelvy |
| Astrazeneca Pharmaceuticals Lp | $108.73 | 2020-2022 | |
| Glaxosmithkline, LLC. | $108.48 | 2020-2023 | Ojjaara |
| Bayer Healthcare Pharmaceuticals INC. | $108.27 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $102.04 | 2019-2024 | Lynparza, Keytruda, Welireg |
| Janssen Pharmaceuticals, INC | $99.24 | 2019-2022 | |
| Intuitive Surgical, INC. | $92.21 | 2023 | Da Vinci Surgical System |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.